B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 11.13 USD -0.27% Market Closed
Market Cap: 901.2m USD
Have any thoughts about
Bioventus Inc?
Write Note

Bioventus Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bioventus Inc
Cash Equivalents Peer Comparison

Comparables:
HAE
ICUI
ALGN
LNTH
MMSI

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioventus Inc
NASDAQ:BVS
Cash Equivalents
$37m
CAGR 3-Years
-25%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Cash Equivalents
$299.3m
CAGR 3-Years
16%
CAGR 5-Years
22%
CAGR 10-Years
9%
ICU Medical Inc
NASDAQ:ICUI
Cash Equivalents
$302.6m
CAGR 3-Years
-13%
CAGR 5-Years
1%
CAGR 10-Years
3%
Align Technology Inc
NASDAQ:ALGN
Cash Equivalents
$1B
CAGR 3-Years
-6%
CAGR 5-Years
16%
CAGR 10-Years
19%
Lantheus Holdings Inc
NASDAQ:LNTH
Cash Equivalents
$866.4m
CAGR 3-Years
112%
CAGR 5-Years
62%
CAGR 10-Years
41%
Merit Medical Systems Inc
NASDAQ:MMSI
Cash Equivalents
$523.1m
CAGR 3-Years
97%
CAGR 5-Years
70%
CAGR 10-Years
55%

See Also

What is Bioventus Inc's Cash Equivalents?
Cash Equivalents
37m USD

Based on the financial report for Dec 31, 2023, Bioventus Inc's Cash Equivalents amounts to 37m USD.

What is Bioventus Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-3%

Over the last year, the Cash Equivalents growth was 16%. The average annual Cash Equivalents growth rates for Bioventus Inc have been -25% over the past three years , -3% over the past five years .

Back to Top